Mesoblast readies for FDA approvals fight in USA
MELBOURNE: Mesoblast has updated investors on its plans for the next six months, revealing it
MELBOURNE: Mesoblast has updated investors on its plans for the next six months, revealing it
FEATURED
Transforming public health through social innovation
Thousands of elderly people evicted from care homes every year
Pilot study to improve staff interactions with residents with dementia
Psychological research informs how to maximise well-being during retirement
New affordable housing for seniors, veterans and disabled people created
Once-a-day Alzheimer’s pill reaches US approval milestone
INNOVATION
